Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection

NCT02134886 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

48

Enrollment

NIH

Sponsor class

Stopped No Accrual

Conditions

HIV Infection
Recurrent Non-Small Cell Lung Carcinoma
Stage IIIA Non-Small Cell Lung Cancer
Stage IIIB Non-Small Cell Lung Cancer
Stage IV Non-Small Cell Lung Cancer

Interventions

DRUG: Erlotinib Hydrochloride
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study
OTHER: Quality-of-Life Assessment

Sponsor

National Cancer Institute (NCI)